(Q44010985)

28 November 2017

0 references

1 reference

title

The past, present and future of hypertension management: a potential role for AT(1)-receptor antagonists (English)

1 reference

28 November 2017

Hollenberg NK

1

1 reference

28 November 2017

Sever PS

series ordinal

2

1 reference

28 November 2017

publication date

1 March 2000

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

28 November 2017

published in

1 reference

28 November 2017

volume

1

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

5-10

1 reference

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Chymase-dependent angiotensin II forming systems in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the ‘white-coat’ effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

Study on COgnition and Prognosis in the Elderly (SCOPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.011

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2000.011

0 references

1 reference